The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ALTABA INC | COM | 021346101 | 106,092 | 5,446,180 | SH | SOLE | 5,446,180 | 0 | 0 | ||
| AT&T INC | COM | 00206R102 | 85,380 | 2,256,331 | SH | SOLE | 2,256,331 | 0 | 0 | ||
| AVAYA HLDGS CORP | NOTE 2.250% 6/1 | 05351XAB7 | 1,542 | 1,800,000 | PRN | SOLE | 1,800,000 | 0 | 0 | ||
| BERKSHIRE HATHAWAY INC DEL | CL A | 084670108 | 312 | 1 | SH | SOLE | 1 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 32,387 | 139,107 | SH | SOLE | 139,107 | 0 | 0 | ||
| BLACKBERRY LTD | COM | 09228F103 | 56,279 | 10,719,892 | SH | SOLE | 10,719,892 | 0 | 0 | ||
| CELGENE CORP | COM | 151020104 | 100,094 | 1,008,000 | SH | SOLE | 1,008,000 | 0 | 0 | ||
| ILLUMINA INC | NOTE 0.500% 6/1 | 452327AH2 | 49,155 | 36,961,000 | PRN | SOLE | 36,961,000 | 0 | 0 | ||
| INCYTE CORP | COM | 45337C102 | 27,717 | 373,387 | SH | SOLE | 373,387 | 0 | 0 | ||
| SPRINT CORPORATION | COM | 85207U105 | 38,690 | 6,270,634 | SH | SOLE | 6,270,634 | 0 | 0 | ||
| VERTEX PHARMACEUTICALS INC | COM | 92532F100 | 12,970 | 76,558 | SH | SOLE | 76,558 | 0 | 0 | ||
| ZAYO GROUP HLDGS INC | COM | 98919V105 | 46,299 | 1,365,744 | SH | SOLE | 1,365,744 | 0 | 0 | ||